SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-010791
Filing Date
2024-03-13
Accepted
2024-03-13 08:08:24
Documents
16
Period of Report
2024-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aadi-20240313.htm   iXBRL 8-K 27082
2 EX-99.1 aadi-20240313xex991.htm EX-99.1 108849
6 EX-99.1 aadilogo-pressrelease.jpg GRAPHIC 5379
  Complete submission text file 0001628280-24-010791.txt   281014

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20240313.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20240313_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20240313_pre.xml EX-101.PRE 13040
17 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20240313_htm.xml XML 2832
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 24744637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)